Application no. and date | 19880770.3 (espacenet) (Federated) (European Patent Register), 20191101 | Patent/reg. no. and date | DK/EP 3875085, 20240619 | Publication date | 20210908 | Priority no. and date | JP 2018207646, 20181102 | EP pub. no. and date |
EP 3875085 20210908 | Effective date | | Applicant/owner | Mitsubishi Tanabe Pharma Corporation, 3-2-10, Dosho-machi, Chuo-ku,
Osaka-shi, Osaka 541-8505, JP | Applicant ref. no. | 170014/BT/GP | Inventor | HAYAMA, Tetsuo, c/o Mitsubishi Tanabe Pharma Corporation, 3-2-10, Dosho-machi, Chuo-ku
Osaka-shi, Osaka 541-8505, JP, TAKAHASHI, Tomohiro, c/o Mitsubishi Tanabe Pharma Corporation, 3-2-10, Dosho-machi, Chuo-ku
Osaka-shi, Osaka 541-8505, JP, OMURA, Tomoyuki, c/o Mitsubishi Tanabe Pharma Corporation, 3-2-10, Dosho-machi, Chuo-ku
Osaka-shi, Osaka 541-8505, JP, HAYASHI, Kouji, c/o Mitsubishi Tanabe Pharma Corporation, 3-2-10, Dosho-machi, Chuo-ku
Osaka-shi, Osaka 541-8505, JP, MATSUDA, Munetomo, c/o Mitsubishi Tanabe Pharma Corporation, 3-2-10, Dosho-machi, Chuo-ku
Osaka-shi, Osaka 541-8505, JP, MIYAZAWA, Tadashi, c/o Mitsubishi Tanabe Pharma Corporation, 3-2-10, Dosho-machi, Chuo-ku
Osaka-shi, Osaka 541-8505, JP | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 31/4152 (2006.01) , A61K 47/32 (2006.01) , A61K 47/36 (2006.01) , A61K 47/38 (2006.01) , A61K 9/10 (2006.01) , A61P 21/02 (2006.01) , A61P 25/28 (2006.01) | Title | Edaravon-suspension til oral indgivelse | Int. application no. | JP2019043013 | Int. publication no. | WO2020091036 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|